Therefore, the therapeutic potential Nrf2 activation strategies to suppress CRPC outgrowth post-ADT will need to be directed towards the blockade of novel AR-independent mitogenic signaling networks in PCa cells. Here, NFE2L2 is linked to posterior cortical atrophy.